Filing Flows › DexCom (DXCM) › Q3 2026
DexCom (DXCM) Q3 2026 earnings results (third quarter 2026)
10-Q filed Oct 29, 2026
DexCom (DXCM) reported revenue of $1.3B for the third quarter 2026 (Q3 2026), +11% from a year earlier and +3% from the quarter before. Operating margin was 24.3%, net earnings $275M (20.5% of revenue).
DexCom, Q3 2026: revenue $1.3B (+11% year over year), operating margin 24.3%, net earnings $275M, operating cash flow $326M. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.3B | +3% | +11% |
| Gross profit | $864M | +4% | +18% |
| Operating profit | $327M | +3% | +35% |
| Net earnings | $275M | +10% | -3% |
| Operating cash flow | $326M | +21% | -51% |
| Free cash flow | $273M | +48% | -53% |
What changed
Revenue was $1.3B in Q3 2026, up 11% year over year and up 3% from the previous quarter.
Gross margin was 64.3%, up 3.8 points from Q3 2025. Operating profit was $0.33B, a 24.3% margin (up 4.3 points year over year). Of the extra revenue versus Q3 2025, 63% reached operating profit, above the 20% margin then. Operating expenses grew 10% against revenue growth of 11%. The fastest-growing cost line was SG&A (+13%). Net earnings were $0.28B, down 3% year over year. The effective tax rate was 17.8%.
Operating cash flow was $0.33B (down 51% year over year), 118% of net earnings. Non-cash charges added back $0.07B of depreciation and amortization and $0.04B of share-based compensation. Working capital and other items used $0.06B. Capital expenditures of $0.05B left free cash flow of $0.27B.
Questions
What was DexCom's revenue in the third quarter 2026?
DexCom (DXCM) reported revenue of $1.3B for the third quarter 2026 (Q3 2026), +11% from a year earlier and +3% from the quarter before.
Was DexCom profitable in the third quarter 2026?
Operating profit was $327M (24.3% of revenue) and net earnings $275M.
Source: DexCom 10-Q on SEC EDGAR.